This site is intended for healthcare professionals

Enhertu approved in the EU for the treatment of HER2-positive metastatic breast cancer.

Read time: 1 mins
Last updated:21st Jan 2021
Published:21st Jan 2021
Condition: Breast Cancer HER2+
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest